These likely include: Melanotan II linked to skin cancer risk and cardiovascular concerns GHRP-2 and GHRP-6 growth hormone secretagogues with more complex side effect profiles CJC-1295 associated with cardiac side effects in some reports Cathelicidin LL-37 antimicrobial peptide with limited human safety data PEG-MGF pegylated growth factor with limited clinical evidence Note that these categorisations are speculative until the FDA formally publishes its updated list
Deanfield J, Lincoff AM, Kahn SE, Emerson SS, Lingvay I, Scirica BM, et al
Koob, Ph.D., a 1999 BBRF Distinguished Investigator
They facilitate weight loss by slowing gastric emptying
Combining the activation of the two receptors, greater improvement of -cell function offers more effective treatment of diabetes and obesity with fewer adverse effects than selective GLP-1R agonists
J Water Process Eng 42:102148 Yadav G et al (2023) A comprehensive review on low-cost waste-derived catalysts for environmental remediation